Idiopathic Macular Telangiectasia Type 2
📧 Sign up to get email alerts when something new happens for Idiopathic Macular Telangiectasia Type 2.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.). [Phase 2]
A Phase 2 open-label study evaluated Anecortave acetate (15 mg) for idiopathic perifoveal telangiectasia, and the trial has completed.